A PYMNTS Company

US: Johnson & Johnson to buy Abbott’s vision unit for $4.33 Bn

By  |  September 18, 2016

Johnson & Johnson said Friday that it is paying more than $4.3 billion in cash to buy the eye health unit of Abbott Laboratories as it seeks to boost its vision business.

The unit, called Abbott Medical Optics, makes lasers and other equipment used for cataract surgeries and laser vision correction procedures. It also makes eye drops and cleaners for contact lenses. AMO posted sales of $1.1 billion last year.

Johnson & Johnson said that the purchase will enter it into the cataracts surgery market and grow its own vision business, which includes Acuvue contact lenses. The New Brunswick, New Jersey, company makes baby shampoo, blood testing equipment and other health care products.

Abbott, based in North Chicago, Illinois, said that it is selling the unit to focus on its treatments for the heart and arteries and its disease testing equipment.

The deal is subject to antitrust clearance and is expected to close in the first quarter of 2017.

Full Content: CNS News

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.